Jim Simons Eye Point Pharmaceuticals, Inc. Transaction History
Renaissance Technologies LLC
- $63.4 Billion
- Q4 2024
A detailed history of Jim Simons (Renaissance Technologies LLC) transactions in Eye Point Pharmaceuticals, Inc. stock. As of the latest transaction made, Renaissance Technologies LLC holds 137,500 shares of EYPT stock, worth $862,124. This represents 0.0% of its overall portfolio holdings.
Number of Shares
137,500
Previous 187,437
26.64%
Holding current value
$862,124
Previous $1.5 Million
31.6%
% of portfolio
0.0%
Previous 0.0%
Shares
10 transactions
Others Institutions Holding EYPT
# of Institutions
156Shares Held
72.4MCall Options Held
187KPut Options Held
225K-
Cormorant Asset Management, LP Boston, MA8.33MShares$52.2 Million4.9% of portfolio
-
Suvretta Capital Management, LLC New York, NY6.78MShares$42.5 Million2.1% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA5.75MShares$36.1 Million0.08% of portfolio
-
Franklin Resources Inc San Mateo, CA4.14MShares$25.9 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.8MShares$23.8 Million0.0% of portfolio
About EyePoint Pharmaceuticals, Inc.
- Ticker EYPT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 34,072,200
- Market Cap $214M
- Description
- EyePoint Pharmaceuticals, Inc., a pharmaceutical company, develops and commercializes ophthalmic products for the treatment of eye diseases in the United States, China, and the United Kingdom. The company provides ILUVIEN, an injectable sustained-release micro-insert for treatment of diabetic macular edema; YUTIQ, a fluocinolone acetonide intrav...